Bogle Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,217
Closed -$5.79M 284
2019
Q4
$5.79M Buy
+9,217
New +$4.51M 0.54% 71

Other funds holding CDLX

Bogle Investment Management's CDLX Position: Q1 2020 in Review

Bogle Investment Management sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 9,217 shares — an estimated $5.79M sold.

Bogle Investment Management first reported a position in CDLX in Q4 2019 and held it in 1 quarter. The position peaked at $5.79M in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • Bogle Investment Management reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • Bogle Investment Management sold 9,217 Cardlytics shares in Q1 2020, an estimated $5.79M.
  • Bogle Investment Management first reported a position in Cardlytics in Q4 2019 and held it in 1 quarter.
  • Bogle Investment Management's Cardlytics position peaked at $5.79M in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Bogle Investment Management's 13F filing for Q1 2020, filed 13 May 2020.